Verastem reported $19.58M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
AstraZeneca AZN:LN 12.3B 763M
Cytokinetics CYTK:US $ 81.7M 4.39M
Immunogen IMGN:US $ 60.93M 1.62M
Novartis NOVN:VX 10.96B 826M
Tg Therapeutics TGTX:US $ 95.27M 8.11M
Verastem VSTM:US $ 19.58M 4.73M
Ziopharm Oncology ZIOP:US $ 9.08M 1.97M